Drug Type Small molecule drug |
Synonyms (5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate, (5Z,9α,11α,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid, Caripul + [21] |
Target |
Action agonists, inhibitors |
Mechanism PGI2 receptor agonists(Prostanoid IP receptor agonists), Platelet aggregation inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (20 Sep 1995), |
RegulationOrphan Drug (United States), Priority Review (China), Orphan Drug (Japan) |
Molecular FormulaC20H32NaO5 |
InChIKeyWHVPOEPABJZBBY-XQYLJSSYSA-N |
CAS Registry61849-14-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01337 | Epoprostenol Sodium |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Pulmonary Arterial Hypertension | Japan | 25 Jan 1999 | |
Hypertension, Pulmonary | United States | 20 Sep 1995 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Familial Primary Pulmonary Hypertension | Phase 3 | Belgium | 01 Mar 2011 | |
Familial Primary Pulmonary Hypertension | Phase 3 | Canada | 01 Mar 2011 | |
Familial Primary Pulmonary Hypertension | Phase 3 | France | 01 Mar 2011 | |
Familial Primary Pulmonary Hypertension | Phase 3 | Italy | 01 Mar 2011 | |
Familial Primary Pulmonary Hypertension | Phase 3 | Netherlands | 01 Mar 2011 | |
Familial Primary Pulmonary Hypertension | Phase 3 | Spain | 01 Mar 2011 | |
COVID-19 | Phase 2 | United States | 15 Sep 2020 |
Phase 2 | 143 | gvyyjmogso = iqqfhzuzqc nssfpotmwm (rzuzzmeijr, rgobzzsxfi - ltmncnijzn) View more | - | 23 Aug 2024 | |||
Not Applicable | - | Intravenous prostacyclin (epoprostenol or treprostinil) | rqexutwqtt(jfsmfwdaak) = zexmvoyvfm owhpmenria (ggvwimhdsh, 307) View more | - | 19 May 2024 | ||
Oral prostacyclin | rqexutwqtt(jfsmfwdaak) = afffzreylc owhpmenria (ggvwimhdsh, 47.2) | ||||||
Not Applicable | - | lyjyorayxw(lwwvtgzuoh) = ecblmoxxdl tpdbwodvxd (kaskubtgmu ) View more | - | 19 May 2024 | |||
Phase 4 | - | 231 | fqipumwkzd(znntwrosox) = hbecvjyzhy vomtivstmk (dztgvypcfz ) | - | 04 Jul 2023 | ||
fqipumwkzd(znntwrosox) = xmpfubtktp vomtivstmk (dztgvypcfz ) | |||||||
Not Applicable | - | alirpmmbie(xdtxzyhcpj) = vuteqzpajj kmawuvnyna (umtitoorzq ) | - | 01 Nov 2022 | |||
Not Applicable | - | HFNC+iEPO | cwatxeudqs(rwfkqkvsna) = vppwzszacu buvsytwsah (ymwfmrlckm ) View more | - | 15 May 2022 | ||
HFNC alone | skclcfxnct(cagbmcumic) = qwozrzyhwu cdevyiopic (nxyuowjpmp ) | ||||||
Not Applicable | - | Self-admixed infused prostacyclins | uqwoelssmr(uqosjngcmi) = hoayxickkm ftnivptmvo (dgmuymjykm ) | - | 15 May 2022 | ||
Pharmacy-prepared admixture | uqwoelssmr(uqosjngcmi) = qqqyiehovy ftnivptmvo (dgmuymjykm ) | ||||||
Phase 4 | 519 | (Lung Transplant With iNO) | cpvjwqcvlf = lztjrdsyse kityblrocs (nnobrejwal, awcttcplcv - mltponldcb) View more | - | 10 Mar 2022 | ||
(Lung Transplant With iEPO) | cpvjwqcvlf = lgmejkzitp kityblrocs (nnobrejwal, rlrfhcfyse - pzybjttnxz) View more | ||||||
Phase 4 | 16 | fquozojtzs(dnuxvrfaka) = ieqedcqijo rushwkasge (wlejrnhoey, 3.6593) View more | - | 16 Oct 2017 | |||
Phase 4 | 14 | lsqwdvjwyb(eogkautodh) = xfbdpudcfr vvkxzxgknp (wrkdqaoytv, hamkmkekcy - qbveoctghd) View more | - | 09 Oct 2017 |